↓ Skip to main content

The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report

Overview of attention for article published in BMC Cancer, April 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
40 Mendeley
Title
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report
Published in
BMC Cancer, April 2019
DOI 10.1186/s12885-019-5604-6
Pubmed ID
Authors

Marzia Del Re, Eleonora Rofi, Carla Cappelli, Gianfranco Puppo, Stefania Crucitta, Simona Valeggi, Antonio Chella, Romano Danesi, Iacopo Petrini

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 15%
Other 5 13%
Student > Bachelor 4 10%
Student > Doctoral Student 3 8%
Researcher 2 5%
Other 5 13%
Unknown 15 38%
Readers by discipline Count As %
Medicine and Dentistry 9 23%
Biochemistry, Genetics and Molecular Biology 7 18%
Neuroscience 2 5%
Agricultural and Biological Sciences 2 5%
Nursing and Health Professions 1 3%
Other 3 8%
Unknown 16 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2024.
All research outputs
#8,483,095
of 25,930,295 outputs
Outputs from BMC Cancer
#2,317
of 9,149 outputs
Outputs of similar age
#144,089
of 365,828 outputs
Outputs of similar age from BMC Cancer
#57
of 227 outputs
Altmetric has tracked 25,930,295 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 9,149 research outputs from this source. They receive a mean Attention Score of 4.8. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,828 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 227 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.